Andrew D Posner1, Jonathan H Soslow2, W Bryan Burnette3, Aihua Bian4, Ayumi Shintani4, Douglas B Sawyer5, Larry W Markham2. 1. Vanderbilt University, Nashville, TN, United States. 2. Department of Pediatrics, Division of Pediatric Cardiology, Vanderbilt University Medical Center, 2200 Children's Way, Suite 5230 DOT, Nashville, TN, United States. 3. Department of Pediatrics, Division of Pediatric Neurology, Vanderbilt University Medical Center, Nashville, TN, United States. 4. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, United States. 5. Department of Medicine, Division of Cardiovascular Services, Maine Medical Center, Portland, ME, United States.
Abstract
BACKGROUND: Duchenne muscular dystrophy (DMD) is characterized by progressive skeletal muscle and cardiac dysfunction. While skeletal muscle dysfunction precedes cardiomyopathy, the relationship between the progressive decline in skeletal and cardiac muscle function is unclear. This relationship is especially important given that the myocardial effects of many developing DMD therapies are largely unknown. OBJECTIVE: Our objective was to assess the relationship between progression of skeletal muscle weakness and onset of cardiac dysfunction in DMD. METHODS: A total of 77 DMD subjects treated at a single referral center were included. Demographic information, quantitative muscle testing (QMT), subjective muscle strength, cardiac function, and current and retrospective medications were collected. A Spearman rank correlation was used to evaluate for an association between subjective strength and fractional shortening. The effects of total QMT and arm QMT on fractional shortening were examined in generalized least square with and without adjustments for age, ambulatory status, and duration of corticosteroids and cardiac specific medications. RESULTS: We found a significant correlation between maintained subjective skeletal muscle arm and leg strength and maintained cardiac function as defined by fractional shortening (rho=0.47, p=0.004 and rho=0.48, p=0.003, respectively). We also found a significant association between QMT and fractional shortening among non-ambulatory DMD subjects (p=0.03), while this association was not significant in ambulatory subjects. CONCLUSIONS: Our findings allow us to conclude that in this population, there exists a significant relationship between skeletal muscle and cardiac function in non-ambulatory DMD patients. While this does not imply a causal relationship, a possible association between skeletal and cardiac muscle function suggests that researchers should carefully monitor cardiac function, even when the primary outcome measures are not cardiac in nature.
BACKGROUND:Duchenne muscular dystrophy (DMD) is characterized by progressive skeletal muscle and cardiac dysfunction. While skeletal muscle dysfunction precedes cardiomyopathy, the relationship between the progressive decline in skeletal and cardiac muscle function is unclear. This relationship is especially important given that the myocardial effects of many developing DMD therapies are largely unknown. OBJECTIVE: Our objective was to assess the relationship between progression of skeletal muscle weakness and onset of cardiac dysfunction in DMD. METHODS: A total of 77 DMD subjects treated at a single referral center were included. Demographic information, quantitative muscle testing (QMT), subjective muscle strength, cardiac function, and current and retrospective medications were collected. A Spearman rank correlation was used to evaluate for an association between subjective strength and fractional shortening. The effects of total QMT and arm QMT on fractional shortening were examined in generalized least square with and without adjustments for age, ambulatory status, and duration of corticosteroids and cardiac specific medications. RESULTS: We found a significant correlation between maintained subjective skeletal muscle arm and leg strength and maintained cardiac function as defined by fractional shortening (rho=0.47, p=0.004 and rho=0.48, p=0.003, respectively). We also found a significant association between QMT and fractional shortening among non-ambulatory DMD subjects (p=0.03), while this association was not significant in ambulatory subjects. CONCLUSIONS: Our findings allow us to conclude that in this population, there exists a significant relationship between skeletal muscle and cardiac function in non-ambulatory DMDpatients. While this does not imply a causal relationship, a possible association between skeletal and cardiac muscle function suggests that researchers should carefully monitor cardiac function, even when the primary outcome measures are not cardiac in nature.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin Journal: Lancet Neurol Date: 2009-11-27 Impact factor: 44.182
Authors: Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin Journal: Lancet Neurol Date: 2009-11-27 Impact factor: 44.182
Authors: Larry W Markham; Kathi Kinnett; Brenda L Wong; D Woodrow Benson; Linda H Cripe Journal: Neuromuscul Disord Date: 2008-04-23 Impact factor: 4.296
Authors: Jonathan H Soslow; Meng Xu; James C Slaughter; Kimberly Crum; Joshua D Chew; W Bryan Burnette; Yan Ru Su; Kelsey Tomasek; David A Parra; Larry W Markham Journal: J Card Fail Date: 2019-02-11 Impact factor: 5.712
Authors: Jacob A Kaslow; Andrew G Sokolow; Thomas Donnelly; Maciej S Buchowski; Bruce M Damon; Larry W Markham; W Bryan Burnette; Jonathan H Soslow Journal: Neuromuscul Disord Date: 2022-02-04 Impact factor: 3.538
Authors: Mary Killian; Maciej S Buchowski; Thomas Donnelly; W Bryan Burnette; Larry W Markham; James C Slaughter; Meng Xu; Kimberly Crum; Bruce M Damon; Jonathan H Soslow Journal: Neuromuscul Disord Date: 2020-02-20 Impact factor: 4.296
Authors: Talita Dias da Silva; Thais Massetti; Tânia Brusque Crocetta; Carlos Bandeira de Mello Monteiro; Alex Carll; Luiz Carlos Marques Vanderlei; Carlie Arbaugh; Fernando Rocha Oliveira; Luiz Carlos de Abreu; Celso Ferreira Filho; John Godleski; Celso Ferreira Journal: Pediatr Cardiol Date: 2018-04-25 Impact factor: 1.655
Authors: Jonathan H Soslow; Larry W Markham; W Bryan Burnette; Cristi L Galindo; Igor Feoktistov; Frank J Raucci; Bruce M Damon; Douglas B Sawyer; Sergey Ryzhov Journal: Front Pharmacol Date: 2017-12-18 Impact factor: 5.810
Authors: Lee-Jae Guo; Jonathan H Soslow; Amanda K Bettis; Peter P Nghiem; Kevin J Cummings; Mark W Lenox; Matthew W Miller; Joe N Kornegay; Christopher F Spurney Journal: J Am Heart Assoc Date: 2019-08-14 Impact factor: 5.501
Authors: Frank J Raucci; Anand Prakash Singh; Jonathan Soslow; Larry W Markham; Lin Zhong; Wejdan Aljafar; Natasja Lessiohadi; Cassandra P Awgulewitsch; Prachi Umbarkar; Qinkun Zhang; Presley L Cannon; Maciej Buchowski; Joseph T Roland; Erica J Carrier; William B Burnette; Antonis K Hatzopoulos; Hind Lal; Cristi L Galindo Journal: Int J Mol Sci Date: 2020-10-10 Impact factor: 5.923